I tend to prefer Cosentyx and Tremfya since they have the joint indication. Do you think these are coming for the other drugs in these classes?
Featuring Saakshi Khattri , MD |
Assistant Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY